KC, ESRA didn't say anything about AOD9064 as she was away fro a bit. What we did glean was that AOD9064 had been formulated. As mentioned earlier it can take 300 separate formulations to get optimum dose.
No decision had been taken regarding marketing and sales at that point. The crew from POH were all a bit tight lipped on this one other than smug looks all around.
I seemed to have picked up the idea that this works but needs some human trials to make some claims on packaging. Nothing overly strenuous, like Pharmaceutical trials.
But reading through recent announcements ,newsletters and presentations, POH talk indicate that this is a definite product in existance and will be marketed and sold. With the launch early 2011.
There is nothing vague about these statements. ESRA and HARRY don't talk around in circles.
We can only go on what they say. So perhaps a good slow read, might be in order.
I am happy and convinced this is a goer.
PoS
POH Price at posting:
9.9¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)